Cargando…
Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005267/ https://www.ncbi.nlm.nih.gov/pubmed/32029719 http://dx.doi.org/10.1038/s41419-020-2301-y |
| _version_ | 1783494899020070912 |
|---|---|
| author | Einarsdottir, Berglind O. Karlsson, Joakim Söderberg, Elin M. V. Lindberg, Mattias F. Funck-Brentano, Elisa Jespersen, Henrik Brynjolfsson, Siggeir F. Bagge, Roger Olofsson Carstam, Louise Scobie, Martin Koolmeister, Tobias Wallner, Olof Stierner, Ulrika Berglund, Ulrika Warpman Ny, Lars Nilsson, Lisa M. Larsson, Erik Helleday, Thomas Nilsson, Jonas A. |
| author_facet | Einarsdottir, Berglind O. Karlsson, Joakim Söderberg, Elin M. V. Lindberg, Mattias F. Funck-Brentano, Elisa Jespersen, Henrik Brynjolfsson, Siggeir F. Bagge, Roger Olofsson Carstam, Louise Scobie, Martin Koolmeister, Tobias Wallner, Olof Stierner, Ulrika Berglund, Ulrika Warpman Ny, Lars Nilsson, Lisa M. Larsson, Erik Helleday, Thomas Nilsson, Jonas A. |
| author_sort | Einarsdottir, Berglind O. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7005267 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70052672020-02-10 Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma Einarsdottir, Berglind O. Karlsson, Joakim Söderberg, Elin M. V. Lindberg, Mattias F. Funck-Brentano, Elisa Jespersen, Henrik Brynjolfsson, Siggeir F. Bagge, Roger Olofsson Carstam, Louise Scobie, Martin Koolmeister, Tobias Wallner, Olof Stierner, Ulrika Berglund, Ulrika Warpman Ny, Lars Nilsson, Lisa M. Larsson, Erik Helleday, Thomas Nilsson, Jonas A. Cell Death Dis Correction Nature Publishing Group UK 2020-02-06 /pmc/articles/PMC7005267/ /pubmed/32029719 http://dx.doi.org/10.1038/s41419-020-2301-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Einarsdottir, Berglind O. Karlsson, Joakim Söderberg, Elin M. V. Lindberg, Mattias F. Funck-Brentano, Elisa Jespersen, Henrik Brynjolfsson, Siggeir F. Bagge, Roger Olofsson Carstam, Louise Scobie, Martin Koolmeister, Tobias Wallner, Olof Stierner, Ulrika Berglund, Ulrika Warpman Ny, Lars Nilsson, Lisa M. Larsson, Erik Helleday, Thomas Nilsson, Jonas A. Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma |
| title | Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma |
| title_full | Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma |
| title_fullStr | Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma |
| title_full_unstemmed | Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma |
| title_short | Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma |
| title_sort | correction: a patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005267/ https://www.ncbi.nlm.nih.gov/pubmed/32029719 http://dx.doi.org/10.1038/s41419-020-2301-y |
| work_keys_str_mv | AT einarsdottirberglindo correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT karlssonjoakim correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT soderbergelinmv correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT lindbergmattiasf correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT funckbrentanoelisa correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT jespersenhenrik correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT brynjolfssonsiggeirf correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT baggerogerolofsson correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT carstamlouise correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT scobiemartin correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT koolmeistertobias correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT wallnerolof correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT stiernerulrika correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT berglundulrikawarpman correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT nylars correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT nilssonlisam correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT larssonerik correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT helledaythomas correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma AT nilssonjonasa correctionapatientderivedxenograftpreclinicaltrialrevealstreatmentresponsesandaresistancemechanismtokaronudibinmetastaticmelanoma |